Angela Marko, DO
Specialty
Pediatric Pulmonology, Pediatrics
Accepting New Patients
Primary Location
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106
Biography
- Co-Director, Asthma Center, UH Rainbow Babies and Children's Hospital
- Assistant Professor, CWRU School of Medicine
Angela Marko, DO is a specialist and clinical educator in the pediatric pulmonary (lung) disease in the Division of Pediatric Pulmonology, Allergy, Immunology and Sleep Medicine at University Hospitals Rainbow Babies & Children’s Hospital since the completion of her fellowship in 2020. She sees patients at UH Rainbow Babies & Children’s main campus and UH Landerbrook Health Center.
Dr. Marko trains fellows in Cystic Fibrosis outpatient care and is a lecturer in the fellowship's core lecture series. She is also a pulmonary clinic and journal club preceptor.
Dr. Marko is board certified in pediatrics. Her academic interests include severe asthma, immunodeficiency-related pulmonary disease and VCD. Her research focuses on asthma, pulmonary clinical research and quality improvement.
Videos
Watch to find out more about this University Hospitals provider.
Languages Spoken
English
Office Locations
UH Rainbow Babies and Children's Hospital
11100 Euclid Ave
Cleveland, OH 44106
216-844-3506
RBC Rainbow Babies & Childrens
11100 Euclid Ave
Suite: 604
Cleveland, OH 44106
216-286-4355
DO 5850 Landerbrook
5850 Landerbrook Dr
Suite: 220
Mayfield Heights, OH 44124
440-646-8055
Parma Med Arts Ctr 4 Ste 201
6115 Powers Blvd
Suite: 201
Parma, OH 44129
216-844-7700
Certifications & Memberships
- Pediatric Pulmonology - American Board of Pediatrics
- Pediatrics - American Board of Pediatrics
Education
Fellowship | Pediatric Pulmonology
Pediatric Pulmonology - UH Cleveland Medical Center (2017 - 2020)
Residency | Pediatrics
Pediatrics - Uh Cleveland Medical Center (2014 - 2017)
Medical Education
Lake Erie College Of Osteopathic Medicine (2014)
Undergraduate
Ohio University (2009)
Industry Relationships
University Hospitals is committed to transparency in our interactions with industry partners, such as pharmaceutical, biotech, or medical device companies. At UH, we disclose practitioner and their family members’ ownership and intellectual property rights that are or in the process of being commercialized. In addition, we disclose payments to employed practitioners of $5,000 or more from companies with which the practitioners interact as part of their professional activities. These practitioner-industry relationships assist in developing new drugs, devices and therapies and in providing medical education aimed at improving quality of care and enhancing clinical outcomes. At the same time, UH understands that these relationships may create a conflict of interest. In providing this information, UH desires to assist patients in talking with their practitioners about industry relationships and how those relationships may impact their medical care.
UH practitioners seek advance approval for certain new industry relationships. In addition, practitioners report their industry relationships and activities, as well as those of their immediate family members, to the UH Office of Outside Interests annually. We review these reports and implement management plans, as appropriate, to address conflicts of interest that may arise in connection with medical research, clinical care and purchasing decisions.
View UH’s policy (PDF) on practitioner-industry relationships.
As of December 31, 2016, Angela Marko did not disclose any Outside Relationships with Industry.